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Mycosis fungoides (MF) is the most frequently found cutaneous T-cell lymphoma with an unknown aetiology. Several
aetiopathogenetic mechanisms have been postulated, including persistent viral or bacterial infections. We looked for evidence of
Borrelia burgdorferi (Bb), the aetiologic agent of Lyme disease (LD), in a case study of MF patients from Northeastern Italy, an area
with endemic LD. Polymerase chain reaction for the flagellin gene of Bb was used to study formalin-fixed paraffin-embedded lesional
skin biopsies from 83 patients with MF and 83 sex- and age-matched healthy controls with homolocalised cutaneous nevi. Borrelia
burgdorferi-specific sequence was detected in 15 out of 83 skin samples of patients with MF (18.1%), but in none out of 83 matched
healthy controls (Po0.0001). The Bb positivity rates detected in this study support a possible role for Bb in the aetiopathogenesis of
MF in a population endemic for LD.
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Mycosis fungoides (MF) is a relatively rare non-Hodgkin’s
lymphoma arising from extranodal tissue. It is the most common
type of cutaneous T-cell lymphoma (CTCL), characterised by a
typically slow evolution and protracted course. Although previous
epidemiological studies had shown its increasing incidence
(Weinstock and Horm, 1988), this could be an artefact caused
by improved diagnostic techniques (Morales Suarez-Varela et al,
2000). Despite a number of studies, the aetiology of this disease
still remains to be determined. Postulated mechanisms include the
persistence of viral or bacterial agents that could exacerbate and/or
stimulate chronic T-cell clonal expansion and cutaneous inflam-
mation (Siegel et al, 2000; Fierro et al, 2001).
Borrelia burgdorferi (Bb) is the aetiologic agent of Lyme disease
(LD), the most common tick-transmitted disease in the northern
hemisphere (Jaenson, 1991). It is a multisystem inflammatory
disorder, which affects skin, nervous system, cardiovascular
system, joints, muscles and eyes (Scarpa et al, 1994). About 80%
of all LD cases in Europe present cutaneous symptoms (derma-
toborrelioses) (Mullegger, 2004). Erythema migrans, borrelial
lymphocytoma and acrodermatitis chronica atrophicans are three
characteristic dermatoborrelioses, occurring in different clinical
stages of the disease, but borrelial isolation has also been reported
from lesional tissues of various cutaneous disorders (Mullegger,
2004).
The aim of the present study was to evaluate the role of Bb in
pathogenesis of MF in the LD-endemic region of Friuli Venezia
Giulia (FVG) in Northeastern Italy (Ciceroni and Ciarrocchi, 1998).
We analysed skin biopsies of MF patients for the presence of the
specific Bb genome using a highly sensitive polymerase chain
reaction (PCR) method (Lebech, 2002).
MATERIALS AND METHODS
This study included 83 patients with a clinical diagnosis of MF,
who were diagnosed between 1993 and 2003 at the Dermatology
Unit of The University of Trieste in Italy. Clinical data analysed
in this study included age, sex, stage of disease, extracutaneous
tumour involvement and disease duration at the moment of the
histological diagnosis. The study was conducted according to the
Declaration of Helsinki protocols. Lesional tissue biopsies were
reviewed by two dermatopathologists (GG and GS), and classified
according to the criteria of the WHO classification of malignant
lymphoma (Jaffe, 2001) after precise immunohistochemical
evaluation. In all cases, the diagnosis of MF was established
by clinico-histopathological correlation between dermatologist
GT and dermatopathologists GG and GT. Immunostaining was
performed on paraffin-embedded tissue sections in all 83 MF cases
using monoclonal antibodies specific for T-cell-associated antigens
(CD3, CD4 and CD8) and for B-cell-associated antigens (CD20)
and plasma cells.
Formalin-fixed and paraffin-embedded tissues of skin biopsies
from 83 MF patients were examined for the presence of Bb
genome. As controls we used surgical excisions of homolocalised
naevi with the surrounding skin (63 dermal nevi, eight junctional
nevi, six compound nevi and six blue nevi) of 83 healthy subjects,
matched for age, sex and skin location.
Total DNA was extracted from 10mm sections of paraffin-
embedded tissue blocks using a phenol–chloroform method
(Pauluzzi et al, 2004). We avoided a nested PCR because of the
high risk of carryover related to this method. As the DNA extracted
from formalin-fixed and paraffin-embedded tissues is partially
degraded, we decreased the amplicon size to 75 bases and
increased a number of amplification cycles to 70 in order
to improve the sensitivity of the method (a high number of
PCR cycles is suggested for paraffin-embedded tissue analysis)
(Lehmann and Kreipe, 2001; Bonin et al, 2003). Primer sets were
designed in low variability regions of the Borrelia chromosome.
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sThe primers targeted the gene that encodes flagellin, a 41kDa
protein (GenBank X16833) that is conserved in all European
species of Borrelia burgdorferi sensu lato (Schwaiger et al, 2001).
Amplification employed bp 775–793 as the forward primer and bp
849–829 as the reverse primer. The sensitivity and specificity of
the primers has previously been tested (Pauluzzi et al, 2004). Every
PCR reaction was run in duplicate under previously reported
conditions (Pauluzzi et al, 2004).
Pure genomic Bb DNA from Borrelia afzelii, Borrelia garinii and
Borrelia sensu stricto and Bb positive tissues were used as positive
controls. Formalin-fixed and paraffin-embedded biopsies of
acrodermatitis chronica atrophicans and erythema migrans were
used as tissue positive controls. As negative controls, we used
paraffin blocks without tissue and Bb negative tissues, which were
skin lesions positive for Mycobacterium tuberculosis. In the set-up
of the method to assess its specificity, we analysed scrapes of
primary syphilis, the DNA from Mycobacetrium avium and
Candida albicans, as previously reported (Pauluzzi et al, 2004).
As additional critical controls, we have included 36 paraffin-
embedded biopsies of B-cell pseudolymphomas.
Polymerase chain reaction products were confirmed by hybri-
disation with a
32P-labelled probe bp 801–828 internal to
the amplicon, detected and counted using a Cyclon instrument
(Packard) (Pauluzzi et al, 2004).
In Bb positive cases a molecular analysis for the rearrangement
of T-cell receptor-gamma (TCR-g) gene was performed. T-cell
receptor-gamma monoclonality was analysed using a PCR
technique as described by McCarthy et al (1992) and modified
by Department of Dermatology, Medical University of Graz, Graz,
Austria (Massone et al, 2005). Polymerase chain reaction products
were concentrated by precipitation and then resupended in 20mlo f
TE buffer 1 .A1 0 ml aliquot of the PCR product was run on a
3.5% Metaphor agarose gel, stained with ethidium bromide and
viewed under the UV light (Massone et al, 2005). T-cell receptor-
gamma gene rearrangements were considered monoclonal when
one or two bands were produced within the expected size ranges
(75–110 bases) (McCarthy et al, 1992). As positive controls we
used DNA extracted from Jurkat cells and DNA extracted from
non-Hodgkin lymph nodes where a T-cell monoclonality has been
previously assessed.
Statistical analysis was performed with dedicated STATASE8
software (Stata Corporation, TX, USA). The statistical significance
was evaluated by Fisher’s exact test for a 2 2 contingency table (95%
confidence intervals) and one-way analysis of variance (ANOVA) test.
Kruskal–Wallis test was applied to compare age at diagnosis, sex and
disease duration in MF patients positive and negative for Bb genome.
Moreover, to estimate the joint effects of the above-mentioned
covariates on disease duration, the data were analysed by fitting the
Cox proportional hazards regression model. P-values of 0.05 or less
were considered to indicate statistical significance.
RESULTS
In total, 83 MF patients were enrolled in the study, and patient
characteristics are shown in Table 1. Skin biopsies were taken from
MF lesions localised in five cases on the head and neck, in 43 cases
on the trunk, in nine cases on the upper extremities, in 14 cases on
lower extremities, and 12 cases were of unspecified localisation.
The majority of our patients (87%) presented with early-stage
disease (IA–IIA). In total, 13% of our patients had late-stage
disease (IIB–IVB). Duration of the disease varied from 6 months
to 15 years, mean 3.5 years. Immunohistochemistry: all cases
examined were uniformly positive for CD3 and CD4 antigens and
uniformly negative for CD20 and plasma cell antigens, 75% of
samples were also CD8 positive (Figure 1).
The most common histological finding in our cases consisted
of a bandlike upper dermal infiltrate of lymphocytes, fibrosis
of papillary dermis and the infiltration of lymphocytes into
the epidermis (epidermotropism) in the form of either a single
lymphocyte epidermotropism or Pautrier’s microabscesses. Lympho-
cytes infiltrating epidermis showed atypical features such as
hyperchromatic and convoluted or cerebriform nuclei (Figure 1).
Using a sensitive PCR method with specific primers confirmed
by hybridisation with a
32P-labelled Borrelia flagellin gene region
oligonucleotide probe, Bb-specific sequence was detected in 15 out
of 83 lesional skin samples of patients with MF (18.1%), but
in none out of 83 matched healthy controls. The difference
in frequency was significant (Po0.0001). In addition, six out of
36 of B-cell pseudolymphoma controls also tested positive for Bb
genome analysis.
All the 15 MF samples positive for Bb genome were from
patients that had early-stage disease. Seven out of 15 patients
presented with stage IA disease, six had stage IB and two patients
had stage IIA. The difference in stage between the group of Bb
Table 1 Characteristics of patients with mycosis fungoides
Patients’ data
Number of MF samples 83
Average age (years); range 65.5; 32–91
















Figure 1 (A) The most common histological finding in our MF cases: a
bandlike upper dermal infiltrate of lymphocytes, fibrosis of papillary dermis
and the infiltration of lymphocytes into the epidermis (epidermotropism).
(B) A detail of Pautrier’s microabscesses. (C) CD4 positive immunohis-
tochemistry. (D) CD20 negative immunohistochemistry.
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snegative and Bb positive MF samples was not significant
(P¼0.99). No significant differences were detected between Bb
positive and negative patients regarding age (P¼0.313), sex
(P¼0.160) and disease duration (P¼0.590). In the multivariate
analysis, the analysed covariates (age, sex and Bb positive or
negative results) did not have any effect on disease duration
P¼0.596).
In cases positive for the Bb genome, we analysed the TCR-g gene
rearrangements using PCR analysis. A monoclonal T-cell infiltrate
was demonstrated in 12 out of 15 Bb positive cases (80%). In 10
cases, one band in the range of 80–85 bases was observed and in
two cases two bands in the same range were found representing a
biallelic rearrangement of the TCR-g genes (Figure 2) (McCarthy
et al, 1992).
DISCUSSION
We have demonstrated the presence of Bb-specific DNA within
lesional skin biopsies of MF patients, implying that approximately
18% of MF cases in this geographic area are perhaps related to
infection with this organism. Despite LD being endemic in this
region of FVG in Northeastern Italy (Ciceroni and Ciarrocchi,
1998), we have shown that this association is highly significant,
since Bb DNA was not found in any of our healthy control subjects.
To confirm the diagnosis of MF we analysed the TCR-g gene
rearrangements using PCR analysis. The finding of identical
(clonal) TCR-g gene rearrangements in cutaneous T lymphocytes
indicates a malignant proliferation and differs them from a non-
clonal (reactive) T-cell infiltration. Thus, detection of clonal TCR-g
gene rearrangements by PCR is a valuable tool for the diagnosis of
cutaneous or other T-cell lymphomas. Out of 15 Bb positive cases,
12 were found to be positive for the clonal rearrangements of TCR-
g chain gene. The percentage of positive cases (80%) for the TCR-g
gene rearrangement agrees with other studies (Klemke et al, 2002;
Ponti et al, 2005). Negative cases may represent T-cell neoplasms
with rearrangement not in the gamma chain locus but rather in the
V-II family locus (McCarthy et al, 1992).
The diagnosis of MF is dependent on confirmatory tissue biopsy
showing atypical skin-homing (epidermotropic) malignant
T-helper memory phenotype (CD3þ, CD4þ, CD8 , CD45R0þ)
(Fierro et al, 2001). MF is hypothesised to arise through a
persistent antigenic stimulation, leading to an accumulation of
skin-homing T-cells that are defective in Fas-mediated apoptotic
programmed cell death (Tan et al, 1974; Nagasawa et al, 2004).
Although viruses are known to provide chronic immune
stimulation, the findings of their association with MF are
controversial (Pancake et al, 1995; Boni et al, 1996; Nagore et al,
2000; Herne et al, 2003). HTLV-1 is found in adult T-cell
lymphoma and leukemia, and it has been implicated by several
studies in CTCL (Zucker-Franklin and Pancake, 1994; Pancake
et al, 1995; Khan et al, 1996). However, others have not been able
to confirm these findings (Boni et al, 1996; Wood et al, 1996).
Epstein–Barr virus infection has also been previously implicated
in several kinds of lymphomas, including peripheral T-cell
lymphomas (Shimakage et al, 2001; Kanegane et al, 2002). Another
study showed significantly higher CMV seropositivity rates in
early-stage MF patients with normal immune systems and minimal
skin involvement compared with control subjects (Herne et al,
2003). Latent CMV and/or EBV infection could provide chronic
antigen stimulation, induce T-cell proliferation, and adversely
affect the apoptosis of skin-homing memory/helper T-cells.
It has also been suggested that bacterial agents, such as
Staphylococcus aureus (Tokura et al, 1992; Jackow et al, 1997) or
Chlamydia pneumoniae (Abrams et al, 2001), might contribute to
MF pathogenesis by acting as persistent antigens, thus exacerba-
ting and/or perpetuating chronic T-cell expansion and cutaneous
inflammation.
In Europe LD is caused by at least three species: Borrelia
burgdorferi sensu stricto, Borrelia afzelii and Borrelia garinii
(Wilske, 2003). Among the dominant genospecies of Bb isolated in
the FVG region is Borrelia afzelii, with its known tropism for the
skin (Ciceroni et al, 2001). The predominance of Borrelia afzelii in
cutaneous lesions in LD has been already reported in several
European countries (Rijpkema et al, 1997; Robertson et al, 1999;
Ruzic-Sabljic et al, 2000; Ornstein et al, 2001). Strains of this
intracellular pathogen can survive the adaptive immune response
and persist in the skin despite a strong host antibody response
(Pachner et al, 2004). It has been postulated that borrelia interacts
with the complement, inactivating complement regulatory proteins
(Kraiczy et al, 2001, 2002). Others have proved that Bb can hide in
immunoprivileged sites (de Koning et al, 1995; Girschick et al,
1996). The antigen variation of the Bb outer membrane has also
been discussed as a possible strategy for evading the immune
response (Seiler and Weis, 1996; Zhang et al, 1997). Data from
Perticarari et al (2003) suggest that spirochaetes, including Bb, are
able to induce apoptosis in lymphocytes, and that the cells
involved are prevalently CD4.
The immune response in humans with LD is characterised by a
type 1-like cytokine response with the production of gamma
interferon (IFN-g), but no interleukin (IL)-4 (Forsberg et al, 1995;
Oksi et al, 1996). The type 1 (Th-1) immune response with high
production of IFN-g has been suggested to be the optimal response
to all infections caused by intracellular microbes, such as Bb.
It stimulates phagocytosis, the intracellular killing of microbes,
antigen presentation to T cells and secretion of pro-inflammatory
cytokines (Shtrichman and Samuel, 2001). By clearing the
pathogen, the Th-1 immune response would diminish further
antigenic stimulation and allow a switch to a type 2 response
by up-regulation of IL-4 (Spellberg and Edwards, 2001). However,
if the Th-1 response fails to completely clear the infection, a
persistent antigenic stimulation might induce chronic Th-1
immune responses with IFN-g production. Data from Widhe
et al suggest that an initial Borrelia- specific IFN-g response,
followed by up-regulation of IL-4, is associated with non-chronic
manifestations of LD, whereas a persistent IFN-g response may
lead to chronic LD (Widhe et al, 2004).
Cutaneous lesions of MF are characterised by an epidermal
Th1-type cytokine profile consisting of interleukin-2 and IFN-g,
whereas a type 2 cytokine production profile, consisting of IL-4,
is more likely to occur in Se ´zary syndrome, the erythrodermic
variant of MF (Saed et al, 1994). Human IFN-g -inducible protein
10 (IP-10) is secreted by IFN-g -stimulated keratinocytes (Sarris
et al, 1997). It is chemotactic for CD4þ lymphocytes, a major
component of MF lesions, and it probably accounts for the
epidermotropism of CTCL (Sarris et al, 1995).
The inflammatory infiltrate in both the early and late skin
manifestations of Lyme borreliosis is mainly composed of




Figure 2 Examples of polymerase-chain reaction analysis of T-cell
receptor-g gene rearrangements. Lanes 1, 3 and 5 are MF samples positive
for the rearrangements; lanes 2 and 4 are MF cases negative for the
rearrangements. Lane 6 is molecular marker ladder.
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spredominance of CD4þ helper T cells (Silberer et al, 2000).
Epidemiological data from many countries show that LD has
increased significantly in incidence since the 1980s (Jaenson, 1991;
Strle, 1999). The age-adjusted incidence rates of MF in our study
area of 1200000 inhabitants were stable over the period of 6 years
from 1995 to 2000, with the mean annual incidence of 1.9 cases per
100000 person-years for males and 1.3 cases for females (Zanier,
1995–2000).
Given these findings, we suggest that Bb could play a cofactor
role in the aetiology of a proportion of CTCL, of which MF is the
most common type. Recognition that a proportion of CTCL is
related to Bb infection may also have important therapeutic
implications. If a causal link between some cases of MF and Bb
infection could be confirmed, a specific antibiotic therapy might
be useful to improve the disease outcome even though MF is a
T-cell lymphoma. In fact, there are already reports of primary
cutaneous B-cell lymphomas responding to antibiotic therapy
designed to treat Bb infection (Hofbauer et al, 2001) even though
the findings about the association between Bb and B-cell
lymphomas are controversial (Goodlad et al, 2000; Kodama
et al, 2005).
Another example of a tumour associated with chronic bacterial
infection is gastric MALT (mucosa-associated lymphoid tissue)
lymphoma, whose increased risk is clearly associated with
Helicobacter (H) pylori infection, and which is the most frequent
extranodal non-Hodgkin’s lymphoma (Van Krieken and Hoeve,
2000). H. pylori can induce antigen-specific T-cell responses at the
gastric site of infection and, in some cases, drives a long-lasting
polarised Th1 response with the development of specific T cells
leading to the onset of low-grade gastric MALT lymphoma (D’Elios
et al, 2003). The identification and eradication of H. pylori causes
prolonged remission in more than 70% of patients with MALT
lymphoma (Boot and de Jong, 2002).
In conclusion, we have provided significant evidence to support
the concept of antigen-driven lymphomagenesis in CTCL in
response to Bb infection. We could hypothesise that in some
individuals Bb might induce an antigen-specific long-lasting Th1
response leading to the accumulation of cutaneous CD4þ
lymphocytes and their possible neoplastic transformation. A
further assessment of the true incidence of Bb-associated CTCL
is needed, together with further studies to assess the efficacy of
antimicrobial therapy in treating this malignancy.
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